Haoxi Health Technology Limited (NASDAQ:HAO) Short Interest Update

Haoxi Health Technology Limited (NASDAQ:HAO) was the target of a large decline in short interest during the month of May. As of May 29th, there was short interest totaling 68,307 shares, a decline of 97.4% from the May 14th total of 2,664,249 shares. Approximately 14.7% of the shares of the stock are sold short. Based on an average trading volume of 1,396,231 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Haoxi Health Technology in a research report on Tuesday, April 21st. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Haoxi Health Technology Trading Up 1.9%

HAO stock traded up $0.02 during midday trading on Tuesday, reaching $0.98. 6,438,236 shares of the stock were exchanged, compared to its average volume of 1,319,498. The company has a fifty day moving average price of $72.74 and a 200 day moving average price of $123.47. Haoxi Health Technology has a 52 week low of $0.78 and a 52 week high of $285.44.

Haoxi Health Technology Company Profile

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.